HDFC Pharma and Healthcare Fund - Direct - Growth
A Equity Scheme by HDFC Asset Management Company Limited
1Y Returns (CAGR)
17.46%
Expense Ratio
0.95%
as of 01/02/2026
AUM
₹662.16 Cr
Qtr End: Dec 25
NAV
₹18.144
as of 02/03/2026
1Y Returns (CAGR)
17.46%
Expense Ratio
0.95%
as of 01/02/2026
AUM
₹662.16 Cr
Qtr End: Dec 25
NAV
₹18.144
as of 02/03/2026
Historical Performance
Investment growth and SIP performance over time.
Lump Sum mode selected.
₹
Total Invested₹10.0k
Current Value₹18.2k
Abs. Returns82.1%
CAGR28.2%
Growth of ₹10.0k
Loading Chart...
Performance Metrics
Returns, CAGR, and Volatility.
| Period | Returns | CAGR | Volatility |
|---|---|---|---|
| 3M | 1.73% | 7.11% | 14.07% |
| 6M | 2.79% | 5.66% | 12.18% |
| 1Y | 17.46% | 17.46% | 14.05% |
| 3Y | N/A | N/A | N/A |
| 5Y | N/A | N/A | N/A |
Scheme Details
- Launch Date
- 14/09/2023
- Fund Age
- 2.5 years
- Minimum Investment
- ₹100
- Fund House
- HDFC Mutual Fund
- Category
- Equity Scheme
- Sub-category
- Sectoral/ Thematic (Equity Scheme)
Similar Funds
Top funds in the same category and sub-category.
| Scheme | 3Y CAGR (%) | TER (%) | AUM (Cr) |
|---|---|---|---|
| Aditya Birla Sun Life International Equity Fund - Direct - Growth | 18.73% | 2.06% | ₹69.63 |
| DSP Banking & Financial Services Fund - Direct - Growth | - | 0.62% | ₹280.2 |
| SBI BANKING & FINANCIAL SERVICES FUND - Direct - Growth | 25.11% | 0.73% | ₹4,503.48 |
| Mirae Asset Banking and Financial Services Fund - Direct - Growth | 22.16% | 0.56% | ₹344.25 |
| ITI Banking and Financial Services Fund - Direct - Growth | 19.48% | 0.40% | ₹10.21 |
| WhiteOak Capital Pharma and Healthcare Fund - Direct - Growth | - | 0.67% | ₹79.26 |
| Tata Banking & Financial Services Fund - Direct - Growth | 21.35% | 0.52% | ₹899.75 |